Reaction
Obstructive Pancreatitis reporting signals
As of the last recalculation, Obstructive Pancreatitis appears in 725 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ORAL SEMAGLUTIDE (PRR 25.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oral Semaglutide | 61 | 25.9 | 26.0 |
| Tirzepatide | 118 | 24.8 | 24.9 |
| Lanreotide Acetate | 5 | 18.4 | 18.4 |
| Liraglutide | 24 | 14.4 | 14.4 |
| Dulaglutide | 30 | 10.1 | 10.1 |
| Alirocumab | 8 | 9.2 | 9.3 |